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Abstract 
 
 Cancer diseases are associated with the presence of several protein biomarkers.  
Aptasensor arrays may allow early multiple-detection of these biomarkers which can 
make significant improvements in the lives of cancer patients. Clinical studies suggest 
that osteopontin, an overexpressed protein by tumor cells, may be used as a diagnostic 
biomarker for various cancers. The aim of the present work was to establish the optimal 
experimental conditions that allow enhancing the performance of an electrochemical 
dual-aptasensor array for the detection of osteopontin. The aptamer concentration, time 
and temperature of immobilization into the dual-screen printed gold electrodes (Dual-
SPGE) as well as the aptamer-protein interaction time were evaluated using a 2k factorial 
experimental design. DNA and/or RNA aptamers were immobilized on the Dual-SPGE 
via streptavidin-biotin interaction and the evaluation of the best experimental conditions 
was carried out by cyclic and square wave voltammetry using a ferro/ferricyanide solution 
([Fe(CN)6]
3−/4−) as a redox probe. Statistical significant models for both DNA and RNA 
aptamers were established. Temperature and aptamer concentration were found to be the 
most significant parameters. Also, the results pointed out that interaction effects between 
the four parameters were usually statistically significant, showing that there was a 
dependency between aptamer concentration-aptamer immobilization time and between 
temperature-aptamer immobilization time. The optimum experimental conditions found 
for enhancing the performance of the dual-aptasensor array were 4°C, 0.5 µM of aptamer 
concentration, 20 min of aptamer incubation and 30 min of aptamer-osteopontin 
interaction. 
 
 
 
 
 
 
 
 
III 
 
 
Resumo 
 
O cancro é uma doença à qual pode ser associada a presença de diversas proteínas 
nos fluidos biológicos de pacientes com essa patologia, as quais podem ser usadas como 
biomarcadores. Os biossensores à base de vários aptâmeros (aptasensors arrays) podem 
permitir a deteção múltipla desses biomarcadores num estágio precoce da doença, 
podendo proporcionar melhorias significativas na vida dos pacientes com cancro. Estudos 
clínicos sugerem que a osteopontina, é uma proteína sobre-expressa por células tumorais, 
podendo ser utilizada como biomarcador no diagnóstico de vários tipos de cancro. O 
objetivo do presente trabalho foi estabelecer as condições experimentais que 
maximizassem o desempenho de um duplo biossensor eletroquímico contendo dois 
aptâmeros (duplo-aptasensor array) para a deteção de osteopontina. O desenho 
experimental 2k fatorial foi utilizado com o intuito de estudar o efeito da concentração 
dos aptâmeros, tempo e a temperatura de imobilização no elétrodo de trabalho de ouro 
duplo (duplo-SPGE), bem como o tempo de interação aptâmero-proteína. Os aptâmeros 
de ADN e/ou ARN foram imobilizados no duplo-SPGE através da interação biotina-
estreptavidina e a avaliação das melhores condições experimentais foi realizada por 
voltametria cíclica e voltametria de onda quadrada usando uma solução de 
ferro/ferricianeto ([Fe (CN)6]
3-/4-) como solução redox. Para os aptâmeros de ADN e ARN 
foram estabelecidos modelos significativos, sendo a temperatura e a concentração dos 
aptâmeros os parâmetros mais significativos. Além disso, os resultados mostraram que o 
efeito da interação dos 4 parâmetros foi em geral estatisticamente não significativo, 
verificando-se uma dependência do tempo de imobilização dos aptâmeros com a 
concentração dos aptâmeros e com a temperatura aplicada, respetivamente. As condições 
experimentais ótimas estabelecidas de forma a melhorar o desempenho do duplo-
aptasensor array foram uma temperatura de 4ºC, com uma concentração de 0.5 μM para 
dois aptâmeros, após 20 min e 30 min de incubação no duplo-SPGE e de interação 
aptâmeros-osteopontina, respetivamente. 
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Résumé 
 
 Les maladies cancéreuses sont liées à plusieurs biomarqueurs protéiques qui 
peuvent être précocement détectés par des biocapteurs à aptamères et par conséquent des 
améliorations notables peuvent être apportées à la vie des patients. Des études cliniques 
suggèrent que l'ostéopontine, une protéine surexprimée par les cellules tumorales, peut 
être utilisée comme un biomarqueur pour le  diagnostic du cancer. Le but du présent 
travail est d'établir les conditions expérimentales optimales  permettant d'améliorer la 
performance d’un biocapteur éléctrochimique à deux aptamères  pour la détection de la 
protéine ostéopontine. La concentration de l'aptamère, la température et le  temps 
d’immobilization de l’aptamère sur  une électrode en or imprimée par sérigraphie ainsi 
que le temps d'interaction aptamère-protéine ont été évalués en suivant  un plan factoriel 
à deux niveaux. Les aptamères ont été immobilisés sur l’électrode via une interaction 
streptavidine-biotine et l'évaluation des meilleures conditions expérimentales a été 
effectuée par voltammetrie cyclique et par  voltampérométrie à impulsion rectangulaire 
en utilisant une solution de ferro/ferricyanure ([Fe(CN)6]
3-/4-) comme sonde redox. Des 
modèles statistiquement significatifs relatifs aux aptamères d'ADN et d'ARN ont été 
établis. La température et la concentration de l'aptamère ont été les paramètres les plus 
significatifs. L'effet des interactions entre les quatre paramètres a montré qu'il existe une 
dépendance entre la concentration de l'aptamère et le temps d'immobilisation de 
l'aptamère et entre la température et le temps d'immobilisation de l'aptamère. Les 
conditions expérimentales optimales pour améliorer la performance du biocapteur étaient  
20 minutes d'incubation d'aptamère, 30 minutes d'interaction aptamère-ostéopontin, une 
température d’incubation de  4°C  et une concentration d'aptamère de l’ordre de 0,5 μM. 
 
 
 
 
  
V 
 
TABLE OF CONTENTS 
 
Preface and Acknowledgements ....................................................................................I 
ABSTRACT ................................................................................................................... II 
RESUMO ...................................................................................................................... III 
RÉSUMÉ ...................................................................................................................... IV 
LIST OF FIGURES ..................................................................................................... VII 
LIST OF TABLES ..................................................................................................... VIII 
LIST OF SYMBOLS AND ABREVIATIONS .......................................................... IX 
 
CHAPTER 1……………………………………………………………………………. 1 
Context, Aims and Thesis Outline ................................................................................... 1 
1.1. Context and Motivation ..............................................................................................2 
1.2. Research Aims ........................................................................................................... 3 
1.3. Thesis outline ............................................................................................................. 3 
 
CHAPTER 2……………………………………………………………...………….… 5 
Introduction ...................................................................................................................... 5 
2.1. Cancer: a cluster of diseases ...................................................................................... 6 
2.1. Cancer biomarkers...................................................................................................... 7 
2.3. Osteopontin : A potentially important cancer biomarker........................................... 9 
2.4. Osteopontin detection .............................................................................................. 10 
2.5. Biosensor: a promising alternative for osteopontin detection................................... 11 
2.6. Aptasensor: a class of biosensor............................................................................... 11 
2.7. Dual-aptasensor array............................................................................................... 12 
2.7.1. Detection technique............................................................................................... 12 
2.7.2. Immobilization of Aptamers ................................................................................. 16 
2.7.3. Surface materials................................................................................................... 16 
2.8. The two-level factorial design (2k factorial design).................................................. 18 
 
CHAPTER 3 .……………………………………………...……………...……..…… 20 
Materials and methods .................................................................................................... 20 
3.1. Materials .................................................................................................................. 21 
3.1.2. Reagents and solutions.......................................................................................... 21 
VI 
 
3.1.2. Apparatus.............................................................................................................. 22 
3.1.3. Software................................................................................................................ 23 
3.2. Methodology............................................................................................................ 23 
3.2.1. Cleaning and homogenization of the working electrodes...................................... 23 
3.2.2.  Functionalization of the working electrodes......................................................... 23 
3.2.3.  Immobilization of the DNA and RNA aptamers.................................................. 24 
3.2.4.  Electrochemical measurements............................................................................ 24 
3.2.5.  Osteopontin incubation......................................................................................... 24 
3.2.6. Calculation of the current peak decrease................................................................ 25 
3.3. Optimization of the experimental conditions ........................................................... 25 
 
CHAPTER 4 .…………………...……………………………………….....………… 31 
Results and discussion .................................................................................................... 31 
4.1.Effect of the experimental conditions on the response of the developed dual-
aptasensor array............................................................................................................... 33 
4.2. Effect of the type of aptamer and electrochemical technique on the dual-aptasensor 
response.......................................................................................................................... 35 
4.3. Optimization of the experimental conditions............................................................ 36 
 
CHAPTER 5 .……………..…………………………….………………...……..…… 49 
Conclusion and furture perspectives ............................................................................... 49 
 
REFERENCES ………………………………………………...…………………….. 52 
 
 
 
 
 
 
 
 
 
 
VII 
 
LIST OF FIGURES 
 
Figure 2.1: Tertiary structure of the osteopontin............................................................... 9 
Figure 2.2: Cyclic voltammogram................................................................................... 15 
Figure 2.3: Square-wave voltammogram........................................................................ 15 
Figure 3.1: Dual-screen-printed gold electrode (Dual-SPGE)....................................... 22 
Figure 3.2: Electrochemical measurements by the Potentiostat-Galvanostat device..... 22 
Figure 3.3: Steps of creation and analysis of the 2k factorial design.............................. 26 
Figure 4.1: Square wave voltammetry response and cyclic voltammetry response ...... 34 
Figure 4.2: Pareto chart of effects ……………………………………......................... 39 
Figure 4.3: Interaction graphs of factors X1 versus X2 .................................................. 44 
Figure 4.4: Interaction graphs of factors X2 versus X4................................................... 45 
Figure 4.5: Interaction graphs of factors X1 versus X4................................................... 46 
Figure 4.6: Interaction graphs of factors X3 versus X4 .................................................. 47 
Figure 4.7: 3 D surface graphs of the optimal experimental conditions  ....................... 48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VIII 
 
LIST OF TABLES 
 
Table 2.1: List of FDA-approved protein tumor markers currently used in clinical 
practice............................................................................................................................... 8 
Table 3.1: Factors and levels for 2k factorial design....................................................... 26 
Table 3.2: Two-level factorial with center points............................................................ 27 
Table 3.3: 2k factorial design in randomized standard order created by Design-Expert 
software........................................................................................................................... 28 
Table 4.1: Experimental design and results obtained using the 24 factorial design used for 
the optimization of the experimental conditions of the dual-aptasensor array................. 32 
Table 4.2: Results (relative current changes ∆I %) relative to the center 
points............................................................................................................................... 36 
Table 4.3: Two way analysis of variance (ANOVA) of the results................................. 36 
Table 4.4: Calculated effect of the main and interaction effects...................................... 37 
Table 4.5: Analysis of variance (ANOVA) of the four created model and their diagnostic 
residuals.......................................................................................................................... 40 
Table 4.6: Regression parameters of the two models for the responses ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴  and 
∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴…………………………………………………………...……………………    41 
Table 4.7: Regression parameters of the two models for the responses ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴  and 
∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴…………………………………………………………...……………………    42 
 
 
 
 
 
 
 
 
 
 
 
 
 
IX 
 
LIST OF OF SYMBOLY AND ABBREVIATIONS 
ΔEp - potential variation between cathodic and anodic peaks 
ΔI - relative current change 
AE - auxiliary electrode 
Ag/AgCl - silver/silver chloride 
ANOVA - analysis of variance 
CA - cancer antigen 
CV - cyclic voltammetry 
DEPC - diethypyrocarbonate 
DNA - deoxyribonucleic acid 
DPA - 3,3’-dithiodipropionic acid 
EDC - N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride 
ELISA - enzyme-linked immunosorbent assays 
ETA - ethanolamine 
FDA - Food and Drug Administration 
HCC - hepatocellular carcinoma 
HE42 - Human epididymis protein 
Ip - peak current intensity 
Ipa - anodic peak current 
Ipc - cathodic peak current 
KCl - potassium chloride 
Kd - dissociation constants 
KH2PO4 - potassium dihydrogen phosphate 
LSD - least significant difference 
MMPs - matrix metalloproteinases 
NaCl - sodium chloride 
NHS - N-hydroxysuccinimide 
OFAT- one-factor-at-a-time 
ox- oxydation 
PSA - prostate-specific antigen 
X 
 
Pro2PSA1 - pro-prostate specific antigen 
RE - reference electrode 
red - reduction 
RNA - ribonucleic acid 
SAMs - self-assembled monolayers 
SELEX - Systematic Evolution of Ligands by Exponential Enrichment 
SPGEs - screen-printed gold electrodes 
SPSS - Statistical Package for Social Sciences 
SWV - square wave voltammetry 
uPA - urokinase plasminogen activator 
WE - working electrode 
 
 
 
 
 
 
 
 
 
 
 
1 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1 
Context, aims and thesis Outline 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1  Context, aims and thesis outline 
 
2 
 
1.1. Context and motivation 
Proteins are a major class of cancer biomarkers and depending on the 
concentration levels (high or low) they may be used as diagnostic markers (Song et al. 
2014). Osteopontin, as an example of protein biomarker that is involved in all the stages 
of cancer progression, may play an essential role in clinical prognosis and diagnosis 
(Shevde & Samant 2014; Ahmed et al. 2011). Thus, nowadays, the development of 
reliable, sensitive, cost-effective, and specific strategies for detecting and quantifying 
disease-related proteins is of particular importance. Based on the antigen−antibody 
reaction, immunological assays are the most commonly used diagnostic methods for 
protein detection (Li et al. 2016). However, in some cases, the immune assay is faced 
with several considerable challenges and drawbacks such as the requirement of specific 
antibodies, the need of large amounts of samples, and long response times 
(Chatziharalambous et al. 2016; Li et al. 2016; Meirinho 2016). Recently, biorecognition 
elements based on aptamer−protein interaction have gained more attention. Aptamers, 
which are short, single-stranded DNA or RNA able to recognize many targets including 
proteins, possess several features that make them a more effective choice than antibodies 
for diagnostic purposes (Lowe 2008; Moreno 2014). Compared to other detection 
methods, aptamer-based electrochemical biosensors attracted more attention because they 
are more sensitive, more reliable, cheaper and simpler (Meirinho et al. 2015; Arya et al. 
2007). However, aptasensors (aptamer-based biosensors) that employ single aptamer as 
recognition element still have limitations mainly due to the false positive results (Cao et 
al. 2017). Due to this limited specificity, dual-aptasensor arrays, which comprise two or 
more different aptamers towards the same or different targets, gained importance, being 
their usual selectivity acceptable for the early diagnosis of human diseases (Khang et al. 
2017). Several parameters influence the performance of the dual-aptasensor array, in 
particular the incubation temperature, the concentration of aptamers, immobilization time 
of aptamers and contact time between aptamers and proteins (Meirinho 2016). However, 
the study of each effect or all effects using a conventional full design would turn out into 
a quite time consuming task. To overcome this drawback, a 2k factorial design can be 
used allowing the simultaneous optimization of all effects and taking into account their 
possible interactions (Elhalil et al. 2016). Although several aptasensor arrays were 
developed (Bosco et al. 2013; Bai et al. 2013; Feng et al. 2016; Feng et al. 2015), 
statistical design of experiments have been only applied in a few studies (Ugo & Moretto 
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2016). Accordingly, the aim of this work was to establish the optimal experimental 
immobilization conditions, using 2k factorial design, in order to develop an 
electrochemical dual-aptasensor array for the detection of osteopontin with improved 
analytical performance compared to the known performance of single-aptasensor arrays. 
 
1.2. Research Aims 
 The purpose of this work is to model the signal response of the developed 
electrochemical dual-aptasensor array for the detection of osteopontin protein which has 
been reported as a cancer biomarker and optimize the aptamers’ experimental 
immobilization conditions namely, the aptamer concentration, time and temperature of 
immobilization into dual-screen printed gold electrodes (Dual-SPGE) and the aptamer-
protein interaction time, to have a better signal response using a 2k factorial design 
methodology. 
The specific objectives included: 
1. Development of an electrochemical dual-aptasensor array using a previsoulsy 
reported RNA and DNA aptamers specific for the target osteopontin.  
2. Immobilization of the bioreceptors (RNA and DNA aptamers) onto the Dual-SPGE 
via streptavidin-biotin interaction for the simultaneous detection of the protein 
osteopontin. 
3. Evaluation of the best experimental conditions by cyclic and squarewave voltammetry 
using a ferro/ferricyanide solution ([Fe(CN)6]
3−/4−) as a redox probe. 
4. Study of the effect the type of aptamer and electrochemical technique on the dual-
aptasensor response 
5. Predict the response of the aptasensor by a first-order model equation. 
 
1.3. Thesis outline 
This thesis was structured in five chapters that cover the research aims stated 
above: 
- Chapter 1: Describes the context and motivation of this work, states the research aims, 
and provides the thesis outline 
- Chapter 2: Presents the literature review that supports the thesis work.  
- Chapter 3: Lists the materials and methods used in the experimental work as well as the 
steps followed to establish the 2k factorial design and to analyze the obtained results. 
Chapter 1  Context, aims and thesis outline 
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- Chapter 4: Combines the result section and discussion part into a single chapter. This 
chapter sets out the experimental results including the statistical analysis, interprets and 
explains the obtained results and answers the research question. 
- Chapter 5: Involves conclusive comments, observations and perspectives for further 
research on this research subject. 
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2.1. Cancer: a cluster of diseases 
Cancer is a generic term for a large group of diseases that can affect any part of the 
body (Bhatt et al. 2010). Unlike normal cells, cancer cells ignore signals that stop cell 
division and induce cell death process which the body uses to get rid of unneeded, old or 
damaged cells. As a result, extra cells begin to divide without stopping, form tumors and 
spread into surrounding tissues (Misek & Kim 2011). This survival advantage and 
undiminished proliferative potential of cancer cells are caused by alterations in the status 
and expression of primarily three main classes of genes: 
 Proto-oncogenes which are a group of genes encoding for proteins that stimulate cell 
division, inhibit cell differentiation, and halt cell death. This group of genes is important 
for normal human development and for the maintenance of tissues and organs. When a 
proto-oncogene mutates or is highly expressed it turns into an oncogene that can become 
permanently or activated when it is not supposed to be. When this happens, the cell grows 
out of control, which can lead to cancer (Lehman et al. 1991). 
 Tumor suppressor genes are a cluster of genes encoding for proteins that inhibit cell 
proliferation by promoting apoptosis and arresting the cell cycle if DNA is damaged. 
Cells with certain alterations in tumor suppressor genes may divide in an uncontrolled 
manner (Lee & Muller 2010). 
 DNA repair genes, which code for proteins that correct errors arising when cells 
duplicate their DNA prior to cell division. Mutations in DNA repair genes can lead to a 
failure in repair, which in turn allows subsequent mutations to accumulate. The 
accumulation of errors can overwhelm the cell and result in cancer (Wood et al. 2001). 
All of these genetic changes happen over a person’s lifetime as a result of errors that occur 
as cells divide or because of damage to DNA caused by certain environmental exposures 
including physical carcinogens, such as ultraviolet and ionizing radiation, chemical 
carcinogens (such as components of tobacco smoke and aflatoxins) and biological 
carcinogens (like infections from certain viruses, bacteria, or parasites) (Clapp et al. 
2005). When faulty genes are inherited from parents, the risk of cancer is much more 
higher (Harris 2015). 
In response to cancer, normal cells as well as cancer cells produce substances that can be 
found in the blood, urine, stool, tumor tissue, or other body fluids (Gam 2012). These 
substances are called cancer biomarkers. The following section will discuss some 
important cancer biomarkers. 
Chapter 2  Introduction 
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2.2. Cancer biomarkers 
 A biomarker is any substance or process that can be objectively measured as an 
indicator of normal biological processes or pathogenic processes (Henry & Hayes 2012). 
In cancer, a biomarker refers to a substance or process that is indicative of the presence 
of cancer in the body (Mishra & Verma 2010). In terms of the usage of biomarkers, cancer 
biomarkers can be classified into three main categories, namely diagnostic, prognostic 
and predictive biomarkers (Goossens et al. 2015). A diagnostic marker is used to detect 
the presence of the disease, being present in any stage during cancer development (Mishra 
& Verma 2010). Bladder tumor antigen (BTA) and nuclear matrix protein-22 (NMP-22) 
are examples of approved diagnostic biomarkers by the Food and Drug Administration 
(FDA) for bladder cancers (Lau et al. 2009). A prognostic biomarker is used to predict 
the course of the disease and to indicate the aggressiveness of the tumor (Gam 2012). For 
example, the glycoprotein CA125 is a prognostic biomarker of the ovarian cancer (Huang 
et al. 2010). A predictive marker is used to predict the response of a patient to specific 
therapeutic interventions. For instance, the predictive biomarker human epidermal growth 
factor receptor HER2 predicts the response to trastuzumab in breast cancer (Henry & 
Hayes 2012).  
On the basis of biochemical molecules, cancer biomarkers include a broad range of 
entities, such as DNA, RNA, micro RNA, proteins, carbohydrate, lipids, and small 
metabolites, cytogenetic and cytokinetic parameters found in the body fluid (Bhatt et al. 
2010). Proteomic markers are the most important biomarkers because they are the main 
executioner molecules in cells and they are more relevant to the disease state initiation 
and progression (Srivastava et al. 2005). Currently, the only approved biomarkers by the 
Food and Drug Administration (FDA) available for clinical use are protein markers 
(Mishra & Verma 2010). Table 1 lists some of the approved protein biomarkers by FDA 
in current clinical use (Ry et al. 2013). Unfortunately, in general, the available markers 
lack the specificity and sensitivity to be used in early detection (Gam 2012). For example, 
CA15.3, CA27.29, and CEA are breast cancer biomarkers recommended by the FDA but 
they are useful only for monitoring advanced breast cancers (Mirza et al. 2008). 
Therefore, researchers are working hardly in order to identify reliable cancer biomarkers 
that can be effectively be used for early cancer detection. Osteopontin is under study as a 
diagnostic and prognostic cancer biomarker. In fact, several works reported osteopontin 
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as an important candidate marker in human cancer (Psyrri et al. 2017; Hao et al. 2016; 
Ferreira et al. 2016; Nassar et al. 2015; Weber 2011; Ahmed et al. 2011). However, it has 
not yet been used in clinical diagnostics. 
 
Table 2.1: List of FDA-approved protein tumor markers currently used in clinical 
practice (adapted from Ry et al. 2013) 
Biomarker Clinical use Cancer type Specimen 
Pro2PSA1 
Discriminating cancer 
from benign disease 
Prostate Serum 
ROMA (HE4+CA-125) Prediction of malignancy Ovarian Serum 
OVA1 (multiple proteins) Prediction of malignancy Ovarian Serum 
HE42 
Monitoring recurrence or 
progression of disease 
Ovarian Serum 
Fibrin/ fibrinogen degradation 
product (DR-70) 
Monitoring progression of 
disease 
Colorectal Serum 
AFP-L3% 
Risk assessment for 
development of disease 
Hepatocellular Serum 
Circulating Tumor Cells 
(EpCAM, CD45, cytokeratins 
8, 18+, 19+) 
Prediction of cancer 
progression and survival 
Breast 
Whole 
blood 
p63 protein 
Aid in differential 
diagnosis 
Prostate 
FFPE 
tissue 
c-Kit 
Detection of tumors, aid in 
selection of patients 
Gastrointestinal 
tumors 
FFPE 
tissue 
CA319-9 Monitoring disease status Pancreatic 
Serum, 
plasma 
Estrogen receptor (ER) 
Prognosis, response to 
therapy 
Breast 
FFPE 
tissue 
Progesterone receptor (PR) 
Prognosis, response to 
therapy 
Breast 
FFPE 
tissue 
HER-2/neu Assessment for therapy Breast 
FFPE 
tissue 
CA-125 
Monitoring disease 
progression, response to 
therapy 
Ovarian 
Serum, 
plasma 
CA15-3 
Monitoring disease 
response to therapy 
Breast 
Serum, 
plasma 
CA27.29 
Monitoring disease 
response to therapy 
Breast Serum 
Free PSA4 
Discriminating cancer 
from benign disease 
Prostate 
 
Serum 
Thyroglobulin Aid in monitoring Thyroid 
Serum, 
plasma 
1 pro-prostate specific antigen;2 Human epididymis protein; 3 Cancer antigen;4 prostate-specific 
antigen 
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2.3. Osteopontin: A potentially important cancer biomarker 
 Osteopontin (Fig. 2.1) is an acidic glycoprotein rich in arginine, glycine and 
aspartate in the molecular weight range of 33 to 60 kDa (Rangaswami et al. 2006; Sase 
et al. 2012; Ahmed et al. 2011). 
 
Figure 2.1: Tertiary structure of the osteopontin 
 (Sivakumar et al. 2014) 
 
It was first identified as a major protein in bone and subsequently found to be expressed 
by several tissues in the human body such as kidney, brain, macrophages, vascular smooth 
muscle cells and many cells of epithelial linings (Rangaswami et al. 2006). It is also 
overexpressed by tumor cells from multiple cancer types (Shevde & Samant 2014). In 
fact, clinical studies have revealed that higher expression of osteopontin is found in tumor 
tissue and serum of different types of cancers suggesting that osteopontin may be used as 
a diagnostic and prognostic biomarker for various cancers (Weber et al. 2010). Indeed, 
altered osteopontin levels have been associated with breast cancer (Psyrri et al. 2017; 
Macrì et al. 2009), thyroid cancer (Ferreira et al. 2016), colorectal Cancer (Huang et al. 
2016), leukemia (Liersch et al. 2015), lung cancer (Shojaei et al. 2012), gastrointestinal 
stromal tumors (Hsu et al. 2010), ovarian Cancer (Huang et al. 2010), pancreatic (Collins 
et al. 2012) and renal cell carcinoma (Matušan-Ilijaš et al. 2011). Osteopontin acts as an 
important molecule that is involved in all the stages of cancer progression including tumor 
invasion, angiogenesis and metastasis (Ahmed et al. 2011). It acts as an important 
molecule at different steps of the cancer process. Briefly, high levels of osteopontin favor 
the survival and proliferation of cancer cells at the primary site. Osteopontin, then, bind 
to αvβ3 integrin and/or CD44 and activate both the matrix metalloproteinases (MMPs) 
and the urokinase plasminogen activator (uPA) which promote local proteolysis of the 
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basement membrane and enable cancer cells to detach from the primary tumor mass and 
invade the stroma and the surrounding tissue. The expression of osteopontin by tumor 
cells induce the angiogenesis by promoting the migration and adhesion of activated 
endothelial cells. Osteopontin acts as a chemotactic and adhesion molecule for 
macrophages and promotes their infiltration of the tumor.  The presentation of 
osteopontin on the cancer cell surface enables them to sequester and activate complement 
factor H which protect them from the host immune system and enable them to travel and 
reach distant organs. At distant sites, cancer cell forms a secondary colony. Proliferative, 
survival and angiogenenic signals by newly formed metastatic colonies occur similarly to 
those that are used during the early steps of tumor progression (Kothari et al. 2016; 
Rangaswami et al. 2006; Rittling & Chambers 2004).  
Although, osteopontin is found in all body fluids produced normally by body organs, it 
can be suggestive of tumor activity when detected in high amounts in the blood. For 
instance in hepatocellular carcinoma, the plasma osteopontin level in patients with 
hepatocellular carcinoma (HCC) is equal to 178 ng/ml whereas, it is equal to 37.5 ng/ml 
in healthy persons (Salem et al. 2013; Psyrri et al. 2017; Liang et al. 2011). Therefore, 
osteopontin may be envisaged as a possible non specific cancer biomarker. 
 
2.4. Osteopontin detection 
 Without a doubt, the enzyme-linked immunosorbent assay (ELISA) dominates at 
present the field of protein detection and quantification (Li et al. 2016). Bramwell et al. 
(2014) used an ELISA technique to measure the osteopontin levels in plasma samples of 
patients with breast cancer. Generally, ELISA is a biochemical test that uses antibodies 
and an enzyme-mediated color change to detect the presence of an antigen like proteins, 
hormones, peptides, etc. or antibody in a given sample (Gan & Patel 2013). Despite its 
widespread use, some limitations have to be considered. In fact, nonspecific binding of 
the antibody or antigen to the plate will lead to a falsely high-positive result. In addition 
ELISA cannot distinguish between antigenically identical analytes. For instance the same 
ELISA assay will often recognize many or all different isoforms of the same protein in a 
sample. Moreover, the assay requires some specialized equipment, like a 
spectrophotometric microplate reader, large amounts of sample and skilled technicians 
(Chatziharalambous et al. 2016; Li et al. 2016). Therefore, it is urgent to develop new 
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detection techniques for protein cancer biomarkers that circumvent the above mentioned 
limitations of conventional ELISA. 
 
2.5. Biosensor: a promising alternative for osteopontin detection 
Biosensors are powerful analytical devices that consist of a bioreceptor compound 
such as an antibody or nucleic acid immobilized on a transducer surface, which is capable 
of providing a signal due to the interaction between the bioreceptor and the analyte 
(Vigneshvar et al. 2016). Biosensors are able to detect a wide range of analytes in complex 
matrices and have been applied in many fields such as food industry, medical field and 
environmental monitoring. They provide better stability and sensitivity as compared with 
the conventional methods such as enzyme-linked immunosorbent assays, 2-D western 
blotting, and 2-D gel electrophoresis (Kraatz & Amini 2015; Mehrotra 2016). The main 
components of biosensors are: 
- The bioreceptors (biorecognition elements) which could specifically recognize and 
identify target (Han et al. 2010).  
- Signal transducer, which could transform the biological signal into an electrical signal 
with high sensitivity and minimum disturbance to the measured analyte. 
- A display which transforms the measured electrical/optical signal into a digital format 
for end users (Cheng et al. 2009; Han et al. 2010). 
The existing biosensors can be classified into immunosensors, enzymosensors, 
aptasensors, etc. based on the nature of the bioreceptor such as antibodies, enzymes and 
aptamers respectively (Mehrotra 2016). 
 
2.6. Aptasensor: a class of biosensor 
An aptasensor is a particular class of biosensor where the biological recognition 
element is a DNA or RNA aptamer. In an aptasensor, the aptamer recognizes the 
molecular target towards which it was previously selected in vitro (Duan et al. 2016). 
Aptamers refer to artificial nucleic acids DNA or RNA generated from combinatorial 
libraries of oligonucleotides that undergo a selection methodology to bind with high 
affinity and specificity to analytes of interest. This selection methodology is termed 
SELEX (systematic evolution of ligands by exponential enrichment) (Cheng et al. 2009). 
Detailed reviews of the SELEX process can be found in the literature (Ozer et al. 2014; 
Stoltenburg et al. 2007). Compared to other existing biological recognition elements, 
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aptamers exhibit several advantages in terms of stability, design flexibility, and cost-
effectiveness. To name a few, stability to long-term storage and under a wide range of 
buffer conditions, easy synthesis, resistance to denaturation and degradation, reversible 
thermal denaturation and ability to bind to targets with selectivity, specificity, and 
affinity, equal and often superior to those of monoclonal antibodies (Lowe 2008; 
Meirinho et al. 2015; Moreno 2014). 
 
2.7. Dual-aptasensor array 
 A dual-aptasensor array is an aptasensor composed of two different immobilized 
aptamers which are able to bind independently with the same or different targets that are 
present in the sample (Khang et al. 2017). An aptasensor dual-array offers higher 
specificity compared with the uniplexed format (Cao et al. 2017; Song et al. 2014). It is 
expected that aptamer array based technology will become a powerful diagnostic tool. In 
fact, the biotechnology company SomaLogic has developed different enhanced aptamer 
arrays for the discovery of potential biomarkers and has demonstrated their successful use 
(Gold et al. 2010). One of the already available commercial versions of aptamer arrays is 
SOMAscan™ which allows the simultaneous precise measurement of over 1000 proteins 
(Webber et al. 2014).  
Whenever developing a dual-aptasensor array, relevant factors must be considered such 
as the detection technique, the electrode/transducer surface and the immobilization 
method of the bioreceptor. The following section will describe in detail these factors. 
 
2.7.1. Detection technique 
To transform the bioreceptor-target reaction into a detectable signal, several 
transducer technologies can be used. The existing transducers can be classified into 
electrochemical, optical, acoustical, piezoelectric, calorimetric, magnetic and 
micromechanical based on the property to be determined such as electricity; light; sound; 
mass change; heat; magnetism; and viscosity, and pressure respectively (Newman & 
Turner 2007). The most frequently cited in the literature and most common are 
electrochemical aptasensor arrays that hold a leading position among the presently 
available sensors. Indeed, they offer an extensive range of advantages over other existing 
transducers such as low cost, remarkable detection limits, experimental simplicity, 
capability to work with turbid samples, fast response, multi-target detection, and easy 
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miniaturization (Meirinho et al. 2015; Arya et al. 2007). Electrochemical methods are 
generally based on electrochemical processes taking place at an electrode surface. These 
electrochemical processes involve loss of electrons (oxidation) or gain of electrons 
(reduction) that a material undergoes during a redox reaction. These reduction and 
oxidation reactions can be used to evaluate the concentration of chemical species in 
solutions, its kinetics, reaction mechanisms, and chemical status. A standard potential E0 
exists for each redox couple at which the reduced and oxidized forms are present at equal 
concentrations. As a result of an imposed potential on the working electrode with respect 
to the reference electrode (for example, by the use of a potentiostat), the redox couples 
present at the electrode respond to this change and adjust their concentration ratios 
according to the following Nernst’s equation (2.1): 
 
                                                 𝐸 = 𝐸0 + 
𝑅𝑇
𝑁𝐹
ln
[𝑜𝑥]
[𝑟𝑒𝑑]
                                                   (2.1) 
 
where, E0 is standard potential, F is Faraday’s constant, T is absolute temperature, and 
[ox] and [red] are concentrations of oxidation and reduction centers respectively (Arya et 
al. 2007). 
In order to study and understand the electrochemical processes, voltammetric, 
amperometric, potentiometric, impedimetric and conductometric techniques are used to 
measure parameters such as current and potential, current, potential, impedance, and 
conductance, respectively (Meirinho et al. 2015). The measurement of current resulting 
from the application of a potential is known as voltammetry. During voltammetric 
measurements, accurate application of potential functions and the measurement of the 
resultant current are ensured by three electrodes (working, auxiliary or counter, and 
reference electrodes; WE, AE or CE, and RE, respectively) along with the potentiostat 
instrument.  
The resulting plot of the current versus applied potential, called voltammogram, provides 
quantitative and qualitative information about the species involved in the oxidation or 
reduction reaction. Voltammetric techniques possess several analytical advantages which 
include low related observed noise, excellent sensitivity, possibility of multiple detection, 
very large useful linear concentration range for species (10–12 to 10–1 M), large number 
of useful solvents and electrolytes, a wide range of temperatures and  rapid analysis times 
(Mendoza et al. 2015). 
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Different potential function can be applied to the WE to drive the reaction and several 
materials can be used as the working electrode. (Arya et al. 2007). The different 
voltammetric techniques are distinguished from each other primarily by the different 
modes of the potential application. One of these voltammetric techniques is cyclic 
voltammetry (CV) which is a useful and versatile electroanalytical technique for the study 
of electroactive species. In CV, a potential is applied and the resulting current intensity is 
measured in an electrolytic solution. As the applied potential reaches the oxidation 
potential of the analyte, the current will increase and then falls off when the concentration 
of the analyte is reduced close to the electrode surface. Then, the applied potential is 
reversed and reach a potential at which the reduction of product formed, during forward 
scan, starts and produces a current of reverse polarity from the forward scan. The 
reduction and oxidation peaks usually have a similar shape (Fig. 2.2). Anodic peak 
potential Epa, cathodic peak potential Epc, anodic peak current Ipa and cathodic peak 
current Ipc are the measured parameters in CV (Sethi 1994; Farghaly et al. 2014). CV is 
a simple, rapid and sensitive techniques that gives reproducible results and offer the 
possibility to observe the oxidation peak and the reduction peak simultaneously which is 
quite helpful in the investigation of electrolytic processes. For instance, the evaluation of 
the electrode surface such as its stability and purity, the cleaning of the electrode surface, 
the immobilization of the bioreceptor on the electrode surface and the detection of the 
formed complex bioreceptor-target  (Sethi 1994; Meirinho et al. 2015). 
Another voltammetric technique is square wave voltammetry (SWV) (Fig. 2.3) 
which is much more sensitive than CV due to the elimination of the background current 
during the experiment (Ferreira et al. 2011). The major advantage of SWV beside the 
higher sensitivity is its speed. In fact SWV allows a very fast analysis (few seconds) 
(Farghaly et al. 2014; Dias et al. 2017).  
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Figure 2.3:  Square-wave voltammogram 
 
The height of the peak is proportional to the concentration of the electroactive species. 
SWV allows detection limits as low as 10–8M (Mendoza et al. 2015). Other voltammetric 
techniques include Normal Pulse Voltammetry (NPV), Differential Pulse Voltammetry 
(DPV), Polarography, Anodic Stripping Voltammetry, Cathodic Stripping Voltammetry 
and Adsorptive Stripping Voltammetry (Mendoza et al. 2015). 
2.7.2. Immobilization of Aptamers 
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Figure 2.2: Cyclic voltammogram 
Oxydation peak 
Chapter 2  Introduction 
16 
 
 The aptamers immobilization into an electrode surface is a crucial step in 
electrochemical aptasensors development. Many available strategies allow reliable 
immobilization of aptamers so that they retain their biophysical characteristics and 
binding abilities and minimize nonspecific binding event (Radi & Abd-Elgawad 2011). 
The choice of a suitable immobilization strategy is determined by the physicochemical 
properties of both surface and aptamers. Aptamers can be physically adsorbed on the 
surface, covalently attached with functional groups or immobilized by streptavidin-biotin 
interaction (Rhouati et al. 2016). Physical adsorption does not require any aptamer 
modification. It is based on ionic interactions occurring between the negatively charged 
groups of the aptamers and positive charges covering the surface. Although it is a fast and 
simple method, the resulting immobilized aptamers are randomly oriented on the surface 
and desorption can occur by detergent, change of pH or ionic strength (Nimse et al. 2014). 
Covalent attachment methods allow good stability of aptamers and high binding strength 
interactions. They are based on interactions between the surface functional groups, such 
as thiol and amines, and aptamer’s chemical groups. For covalent binding of biomolecules 
on gold surfaces, thiol-metal interactions are frequently used The thiol groups 
demonstrate strong affinity towards the noble metal surfaces allowing the formation of 
covalent bonds between the sulfur and gold atoms (Rhouati et al. 2016). In the 
immobilization by streptavidin-biotin interactions, streptavidin is first linked to the solid 
surface then the biotinylated aptamers form the complex streptavidin-biotin. Streptavidin 
is a tetrameric protein that has four identical binding sites for biotin, which is a small 
molecule, binds with a very high affinity to the streptavidin binding sites (Nimse et al. 
2014). 
 
2.7.3. Electrode surface materials 
 Different materials are available for the preparation of surfaces for biosensing 
applications. They need to fulfill, depending on the measurement technique, special 
requirements, such as electrical conductivity for electrochemical techniques. The most 
common are gold, microporous gold, graphite, glass carbon and indium tin oxide. 
Conducting polymers are another class of materials used for fabricating electrochemical 
biosensors. These include polyaniline, polypyrrole and polystyrene, which can be coated 
onto other sensor substrates usually gold surfaces. This leads to stable surfaces with easy 
handling and excellent redox recyclability (Grieshaber et al. 2008). In the last two decades 
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or so, screen-printing technology has been exploited in biosensors, paving the way for the 
development of a new range of electrode systems. Screen printed electrodes (SPE) usually 
include a three electrode configuration (WE, AE and RE) printed on several kinds of 
plastic or ceramic substrates. This configuration has given SPE an unrivaled power of 
adaptability and excellent accuracy. 
 In recent years, SPE have been extensively employed for developing novel 
electrochemical sensing platforms and improving their performances. This is due to the 
multiple advantages that SPE can offer namely, the reduction of sample volume required 
to as low as few microliters, and the possibility of connecting it to portable 
instrumentation. In addition, SPEs avoid some of the common problems of classical 
electrodes, such as tedious and time-consuming cleaning processes (Taleat et al. 2014). 
Stencils, ink and a squeeze blade are typically used in screen-printing technology. Silver 
ink and carbon ink are the most commonly used during the printing process of SPEs 
(Yamanaka et al. 2016). Silver ink is printed as a conductive track, whereas graphite ink 
is used for the WEs; other materials such as gold, platinum and silver based inks are also 
used. Carbon inks which consist of graphite particles, polymeric binder and other 
additives are a widespread material because they are relatively cheap, easy to modify and 
chemically inert. Gold ink pastes are less employed than carbon because of their higher 
cost (Taleat et al. 2014). However, the affinity between thiol moieties and gold allows 
SPEs with gold WEs to be easily modified with the formation of self-assembled 
monolayers (SAMs), creating a significantly increased interest for gold SPEs to be 
employed in electrochemical biosensors (Yamanaka et al. 2016). The SAMs are used for 
the immobilization of biological recognition elements on the electrode surface. For 
instance, carboxyl groups serve for antibody immobilization, esters for amine couplings 
and biotin can be used to bind streptavidin and further biotin functionalized biomolecules. 
It is important, in electrochemical applications, that the SAM allows electron and analyte 
diffusion (Grieshaber et al. 2008). Some materials, such as, gold, silver, platinum, 
palladium, other metal nanoparticles and carbon nanotubes and graphene based inks allow 
enhanced immobilization efficiency of biological molecules and accelerate the electron 
transfer rate on electrode surface (Taleat et al. 2014).  
It is of utmost importance that, after selecting the electrode surface material, the 
immobilization method and the detection technique, the experimental conditions 
regarding the immobilization steps (namely, concentration, time and temperature) should 
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be optimized and for that experimental design strategies may be used to reduce the 
number of assays and to really establish the best conditions taking into account the 
possible effects of each individual parameters but also the synergetic effect of the 
interactions between parameters. 
 
2.8. The two-level factorial design (2k factorial design) 
 Factorial designs are statistical multivariate techniques that include a series of 
experiments that are designed to evaluate the possible effect of two or more factors, each 
with discrete possible levels, where all possible combinations of the levels of the factors 
are investigated (Aghahosseini et al. 2013). They are widely used in experiments 
involving several factors where it is necessary to study the joint effect of the factors on a 
response. The effect of a factor is defined to be the change in response produced by a 
change in the level of the factor. This is called a main effect because it refers to the 
primary factors of interest in the experiment. If there is an interaction between the factors, 
the difference in response between the levels of one factor is not the same at all levels of 
the other factors (Montgomery 2008). 
 In research work, special cases of the factorial design are widely used. The most 
common of these special cases is the two-level factorial design (2k factorial design) in 
which k factors are studied simultaneously each one at only two levels. The 2k design 
provides the smallest number of runs with which k factors can be studied in a complete 
factorial design. In fact, with three factors, the factorial design requires only 8 runs versus 
16 for an one-factor-at-a-time (OFAT) experiment with equivalent power. The advantage 
of factorial design becomes more pronounced as more factors are added (Anderson. 
2000). In 2k factorial design, the factors with their levels should be fixed, the designs are 
completely randomized, the usual normality assumptions are satisfied and the response is 
assumed to be linear over the range of the factor levels chosen because there are only two 
levels for each factor (Montgomery 2008). 
To check for the accuracy of the fitness, center points are usually incorporated in the 
factorial structure. Center points are created by setting all factors at their midpoint 
between their low and high levels. The center point should be replicated to provide more 
power for the analysis. These points, along with all the others, must be performed in 
random order. The center points act as a barometer of the variability in the system. The 
average response value from the actual center points is compared to the estimated value 
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that comes from averaging all factorial points. If the actual center point value are higher 
or lower than predicted by the factorial design points, there is curvature of the response 
surface in the region of the design (AlcheikhHamdon et al. 2015; Anderson. 2000).  
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3.1. Materials 
 
3.1.1. Reagents and solutions 
Diethypyrocarbonate (DEPC), 3,3’-dithiodipropionic acid (DPA), N-(3-
dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), ethanolamine (ETA) and sulfuric acid (purity of 99.999%) 
were purchased from Sigma-Aldrich. Potassium hexacyanoferrate (III) (K3Fe(CN)6) and 
potassium hexacyanoferrate (II) (K4Fe(CN)6) were acquired from Acros Organics and 
potassium dihydrogen phosphate (KH2PO4) from Merck. Sodium chloride (NaCl), 
potassium chloride (KCl) and sodium hydrogen phosphate (Na2HPO4) were obtained 
from Panreac. Lyophilized recombinant human osteopontin was purchased from R&D 
systems and manipulated according to the manufacturers’ specifications. 
The RNA aptamer and DNA aptamer were synthesized by Integrated DNA Technologies 
(Belgium), their sequences were as follow: RNA aptamer (5’-Biotin- CGG CCA CAG 
AAU GAA AAA CCU CAU CGA UGU UGC AUA GUU G-3’) and DNA aptamer (5’-
Biotin-TGT GTG CGG CAC TCC AGT CTG TTA CGC CGC-3’) (Meirinho 2016). 
Phosphate buffer saline (PBS) solution (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 
and 1.47 mM KH2PO4) with an adjusted pH of 7.4 was used to prepare the 
ferro/ferricyanide redox probe, dilute the working solutions if needed and wash the 
electrodes. The ferro/ferricyanide redox probe (5 mM K3Fe(CN)6 and K4Fe(CN)6 (1:1) 
and 10 mM KCl in 100 mL of PBS), with an adjusted pH of 7.4, was prepared. Stock 
solutions of 200 mM EDC, 100 mM NHS, as well as the stock solution of 1 mg/ml of 
septravidin in PBS (pH 7.4) were stored at -20 ºC before use. Stock solutions of 200 nM 
DPA and 100 mM of ETA were stored at 4 ºC. Stock solution of osteopontin was prepared 
according to the manufacturer specifications and was stored at -20 ºC. The osteopontin 
working solution was obtained by dilution of the stock solutions with PBS buffer and was 
stored at 4 ºC until use. Deionized water (18.2 MΩ) purified by a milli-QTM system 
(Millipore) was used was to rinse the electrode surface and for aqueous solutions 
preparation. Stock solutions of DNA and RNA aptamers were prepared with ultra-pure 
water containing 1% DEPC (v/v) to avoid the RNase interference at 100 μM. The working 
DNA and RNA aptamer solutions were prepared by dilution of the stock solutions using 
PBS. 
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3.1.2. Apparatus 
The (Dual-SPGE) were purchased from DropSens (Oviedo, Spain). They include 
a four-electrode system configuration (two WEs, RE and AE) printed on the same strip 
of ceramic substrate (3.4 x 1.0 x 0.05 cm) and were subjected to low temperature (BT) 
curing ink. They are composed of two ellipses of gold-BT WEs (with a surface of 6.3 
mm2 each) arranged in a parallel way in the ceramic strip, an Ag/AgCl RE and a gold-BT 
CE (19.8 mm2 and 1 mm wide) (Fig. 3.1). A Potentiostat-Galvanostat device (PG580, 
Uniscan Instruments) was used to record CV and SWV signal profiles (Fig. 3.2).  
 
 
 
 
 
 
 
 
 
Figure 3.1: Dual-screen-printed gold electrode (Dual-SPGE) 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Electrochemical measurements by the Potentiostat-Galvanostat device 
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3.1.3. Software 
Two statistical software, Design-Expert and Statistical Package for Social 
Sciences (SPSS), were used for the experimental design and regression analysis of the 
experimental data. The UiEChem™ software was used to study the electrochemical 
processes taking place at the electrodes surfaces. 
 
3.2. Methodology 
 
3.2.1. Cleaning and homogenization of the working electrodes 
The gold surface of the electrode is subjected to ambient contaminants affecting 
electrochemical measurements. In fact, the peak currents in CV and SWV depend on the 
homogeneity and composition of the gold electrode surface (Fischer et al. 2009). For this 
reason, the gold electrode surface must be cleaned before it is chemically modiﬁed for 
the immobilization step. 
The electrode was electrochemically cleaned by successively cycling the electrode using 
three weak sulfuric acid solutions (H2SO4 (0.5 M), KCl (0.01 M)/ H2SO4 (0.1 M) and 
H2SO4 (0.05 M)), under a potential range between -0.3 and +1.5 V at a scan rate of 100 
mV/s. The cleaning procedure ended when a representative cyclic voltammogram of a 
clean gold electrode was obtained. 
In order to ensure the uniformity of the WE, [Fe(CN)6]
-3/-4 solution was used to verify if 
the typical CV or SWV voltammogram of an homogenized gold electrode was reached. 
 
3.2.2. Functionalization of the working electrodes 
The procedure followed to functionalize the WE was previously described in 
Meirinho et al. (2015). The electrode surface must be chemically modified to ensure an 
efficient immobilization of the aptamers. For that, the WE was incubated with DPA 
during 30 min at room temperature in order to form the self-assembled monolayer (SAM) 
then rinsed with deionized water. To facilitate the binding with the amino group of the 
streptavidin, the carboxylic groups of the SAM were activated with EDC and NHS (1:1 
v/v) during 60 min at room, the electrode is then rinsed with deionized water .After that, 
the WE surface was incubated with streptavidin solution overnight at 4 ºC to enable the 
binding of the amine groups with the activated carboxylic groups of the self assembled 
monolayer. To block any remaining activated carboxyl groups, the WE surface was 
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exposed to ETA during 20 min at room temperature. Finally, the electrode was rinsed 
with PBS buffer. 
 
3.2.3. Immobilization of the DNA and RNA aptamers 
 After the functionalization step, the WE is ready for the aptamers immobilization. 
The biotinylated RNA and DNA aptamer solutions were prepared by dilution to the 
desired concentration using PBS buffer. Three different concentrations were studied 
namely, 0.5µM, 1µM and 1.5µM. The pretreatment of the aptamers solution is an 
essential step that allows the formation of a flexible aptamer structure that can interact 
easily with the streptavidin on the WE surface. This step consists in exposing the aptamers 
solution to heat treatment (95 ºC during 5 min, 4 ºC for 5 min and 10 min at room 
temperature). After the heat treatment, the biotinylated aptamer was attached to the 
modified gold surface through the streptavidin–biotin interaction. Different aptamers’ 
immobilization times (20 minutes, 40 minutes and 60 minutes) and different incubation 
temperatures (4°C, 24°C and 44°C) were evaluated (as described in Tables 3.1 to 3.3). 
The electrode was then rinsed with PBS buffer to remove the unbound aptamers. 
 
3.2.4. Electrochemical measurements 
After the aptamers immobilization, 100 µl of [Fe(CN)6]
3-/4- solution (5 mM 
K3Fe(CN)6 and K4Fe(CN)6 (1:1) and 10 mM KCl in 100 mL of PBS) was dropped into 
the chip covering the four electrodes (two WEs, RE and AE) . The electrochemical 
analysis was, then, performed at room temperature using CV (under a potential range 
between -0.4 and 0.65 V at a scan rate of 0.05 V/s) and SWV (under a potential range 
between -0.2 and 0.6 V at a frequency of 25 Hz and a pulse height of 0.025 V). For both 
techniques, the obtained current peak I0 was recorded. 
 
3.2.5. Osteopontin incubation 
Osteopontin solution (200.2 nM) was prepared by solubilizing the lyophilized 
osteopontin in PBS buffer. 2.5 µl of this solution was dropped on each WE and kept at 
different incubation temperatures (4°C, 24°C or 44°C) for 30, 60 or 90 minutes (Tables 
3.1 to 3.3). Then the electrode surface was washed with PBS buffer to remove the 
unbound proteins. 
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3.2.6. Calculation of the current peak decrease 
 After osteopontin incubation, the electrochemical analyses were done as those 
performed after aptamers immobilization and the obtained current peak I1 was recorded. 
For both CV and SWV techniques, the relative current change was calculated according 
to the equation (3.1):  
 
                                             ΔI= (I0 - I1)/I0 x 100                                                      (3.1) 
 
where, ΔI is the relative current change (%), I0 and I1 represents the peak current (mA) 
before and after the sample incubation, respectively. Four signal responses were obtained 
namely ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 , ∆𝐼𝐶𝑉
𝐷𝑁𝐴 and ∆𝐼𝐶𝑉
𝑅𝑁𝐴 which correspond to the relative current change 
when using SWV as electrochemical technique and DNA as aptamer, relative current 
change when using SWV as electrochemical technique and RNA as aptamer, relative 
current change when using CV as electrochemical technique and DNA as aptamer, and 
relative current change when using CV as electrochemical technique and RNA as 
aptamer, respectively 
 
3. Optimization of the experimental conditions 
The performance of the developed dual-aptasensor array can be severely affected 
by the experimental conditions (Meirinho 2016). As previously reported, a 2k factorial 
experimental design was employed in order to find the key factors responsible for a 
significant effect on the electrochemical response of the dual-aptasensor, aiming to 
maximize its response. This technique was used to reduce the number of experiments, 
time, overall process cost and to get a better overall perception of the single and 
simultaneous effects of the parameters under study (Elhalil et al. 2016).  
Fig. 3.3 illustrates the steps taken for the establishment and the analysis of the two-level 
factorial design. Steps 3, 5, 6, 7, 9, 10 and 12 were done using the Design-Expert® 
software. Relevant factors which may affect the aptasensor response were studied. Four 
factors  were chosen,  namely, (X1) aptamer concentration, (X2) time of aptamer 
immobilization into dual-screen printed gold electrodes (Dual-SPGE), (X3) the aptamer-
protein interaction time and (X4) incubation temperature (step 1 in Fig. 3.3). Both factors, 
aptamer concentration and time of aptamer immobilization into dual-screen printed gold 
electrodes (Dual-SPGE), can affect the coverage of the electrode surface with aptamers. 
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The time of aptamer-protein interaction can have an influence on the formation of the 
aptamers-protein complex. The incubation temperature may alter the spatial configuration 
of the aptamer and/or the osteopontin. 
 
 
Figure 3.3: Steps of creation and analysis of the 2k factorial design 
 
Table 3.1: Factors and levels for 2k factorial design 
Real factors 
Coded 
factors (Xi) 
Units 
Low 
level 
(-) 
High 
level (+) 
Aptamer concentration X1 µM 0.5 1.5 
Time of aptamer immobilization into dual-
screen printed gold electrodes (Dual-SPGE) 
X2 min 20 60 
Aptamer-protein interaction time X3 min 30 90 
Incubation temperature X4 °C 4 44 
 
1- Choose the factors that have a potential effect 
on the response of the  aptasensor
2- Set two levels for each factors : the low and 
the heigh levels
3- Build the two-level factorial design
4- Perform the experiments
5- Calculate the main effects
6- Calculate the interaction effects
7- Plot the effect on half-normal plot
8- Select the significant effects
9- Statistical 
analysis
10- Plot main effects and interactions
11- Interpret results
12- Model the response with predictive equation
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The four chosen factors, X1, X2, X3 and X4, are all numerical so they can be adjusted to 
any level. Each studied factor was adjusted to two levels, a low (-) and a high (+) level 
(step 2 in Fig. 3.3). A general rule is to set levels as far apart as possible so it will be more 
likely to see an effect, but not exceed the operating boundaries (table 3.1).  
Once the factors and their levels were set, the 2k factorial design was built by the Design-
Expert® software (step 3 in Fig. 3.3). Because we have four factors, each with two levels, 
the 2k factorial design produces 16 runs (24 = 16). Center points were included into the 
design in triplicate to check for the assumption of linearity in the factor effects, in other 
words, to detect an eventual presence of curvature.  
If the curvature is not significant, the relationship between the aptasensor response (the 
current change) and the chosen factors fits a first-order model (the model will be 
explained in more details in the twelfth step). If the curvature is significant, a second-
order model is more appropriate. Center points are created by setting all factors at their 
midpoints, they correspond to the zero level (table 3.2). 
 
Table 3.2: Two-level factorial with center points 
Coded factors (Xi) Units Low level (-) Center (0) High level (+) 
X1 µM 0.5 1 1.5 
X2 min 20 40 60 
X3 min 30 60 90 
X4 °C 4 24 44 
 
The final generated 2k factorial design, taking into account the three replicates of the 
center points, produces 19 runs. Experiments were conducted as shown in table 3.3 which 
is generated by the Design-Expert® software (step 4 in Fig. 3.3). The run order of the 
design was completely randomized to offset any lurking variables. Four responses of the 
19 runs were recorded and the relative current changes (∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴, ∆𝐼𝐶𝑉
𝐷𝑁𝐴  and 
∆𝐼𝐶𝑉
𝑅𝑁𝐴 ) were determined using equation 3.1.  
The average effect of a factor in a two-level factorial design is defined as the change in 
response produced by a change in the level of that factor averaged over the levels of the 
other factor (Montgomery 2008).   
 
 
Chapter 3  Materials and methods 
28 
 
 
Table 3.3: 2k  factorial design in randomized standard order created by Design-Expert® 
software 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Main effects of each of the chosen factors (X1, X2, X3 and X4 ) were calculated as follows 
(step 4 in Fig. 3.3):  
                                                                                                                        
                                                                                                                                  (3.2)
                                                                  
Where ΔI+ refers to the aptasensor response when the factor is set at the high level and 
ΔI- refers to the aptasensor response when the factor is set at the low level. 
The full-factorial design allows estimation of all six two-factor interactions (X1 
X2, X1 X3, X1 X4, X2 X3, X2 X4, and X3 X4), all four three-factor interactions (X1 X2 X3, 
X1 X2 X4, X1 X3 X4 and X2 X3 X4) , as well as the four-factor interaction (X1 X2 X3 X4). 
The signs of interaction effects is determined by multiplying the signs of parent terms. 
The interaction effects are then calculated using the general formula shown previously 
(equation 3.2) (step 6 in Fig. 3.3). After calculating the effects related to the main and 
interaction effects, their statistical significance was evaluated aiming to verify if their 
std run X1 X2 X3 X4 
10 1 + - - + 
1 2 - - - - 
11 3 - - + + 
9 4 - - - + 
8 5 + + + - 
18 6 0 0 0 0 
7 7 - + + - 
5 8 - + - - 
15 9 - + + + 
19 10 0 0 0 0 
12 11 + - + + 
3 12 - - + - 
13 13 - + - + 
2 14 + - - - 
14 15 + + - + 
6 16 + + - - 
16 17 + + + + 
4 18 + - + - 
17 19 0 0 0 0 
𝐸𝑓𝑓𝑒𝑐𝑡 = ∑ ∆𝐼+
8
 −  ∑ ∆𝐼−
8
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contribution was due to normal variations in the aptasensor response (noise) or not. 
Plotting the absolute value of all effects on a half-normal probability plot, separates the 
effects into large, repeatable effects and the small, likely to be noise effect. The half-
normal plot of effects makes it very easy to see at a glance what is significant (step 7 in 
Fig. 3.3). In the half-normal probability plot, the not statistical significan effects would 
be located on a line near zero whereas the significant effects are off the line. The latter 
are selected in order to establish the model and study the effects of the factors and their 
interactions (step 8 in Fig. 3.3). Effects with no significance can be included to keep a 
hierarchical model. The significance of the model was evaluated (step 9 in Fig. 3.3) using 
analysis of variance (ANOVA). A model having a p-value lower than 0.05 is considered 
significant. In the same way, the main and interaction effects of each factor which have 
p-value <0.05 are significant. The fit of the model was further statistically checked by the 
coefficient of determination R2 and the predicted coefficient of determination (R2 or Q2 
predicted). The R2 value is always between 0 and 1. The closer the R2 value is to 1, the 
better the model predicts the response. It gives an idea of how well current runs can be 
reproduced by the model (Elhalil et al. 2016; Neta et al. 2011). R2 value higher than 0.75 
indicates that the model is good.  
The Q2 value informs about the goodness of prediction, indicating how well new 
experiments can be predicted using the model. A Q2 value higher than 0.60 indicates that 
the model is good. The discrimination ability of the model was also assessed by measuring 
the adequate precision value, which compares the response to the noise ratio. A value 
greater than 4 is envisaged to assure adequate model discrimination (Dominguez et al. 
2012). 
If the model created is not significant or the R2 value is lower than 0.75 or the Q2 value 
is lower than 0.25 or the adequate precision value is lower than 4, a new model terms 
from the half-normal probability plot should be selected and new model should be 
created. 
If the statistical analyses do not reveal any problem in the model, we plot and interpret 
interactions. The interaction graphs show lines bracketed by least significant difference 
(LSD) bars at either end. If the LSD bars do not intersect or overlap, this means that the 
effects are significantly different. 
In a 2k factorial design, it is easy to express the results of the experiment in terms of a 
predictive equation (step 11 in Fig. 3.3). The following equation (equation 3.3) represents 
the model used to predict the response of the dual-aptasensor array: 
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∆𝐼 = 𝛽0 + ∑ 𝛽𝑖𝑋𝑖
4
𝑖=1  +  ∑ 𝛽𝑖𝑗𝑋𝑖𝑋𝑗
6
𝑖<𝑗 + ∑ 𝛽𝑖𝑗𝑘𝑋𝑖𝑋𝑗
3
𝑖<𝑗<𝑘 𝑋𝑘 + 𝛽1234𝑋1𝑋2𝑋3𝑋4        (3.3) 
 
Where ∆𝐼 is the predicted response (the relative current change in percentage); the β’s are 
parameters whose values are to be determined using the linear regression model, being β0 
the intercept, βi and βj the linear coefficients and βij, βijk  and β1234  the interaction 
coefficients and X1, X2, X3 and X4 are the coded factors (Dominguez et al. 2012). 
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Electrochemical aptasensors have been attracting a great attention in several fields 
such as, clinical diagnosis, environmental monitoring and food analysis, mainly due to 
their high sensitivity, rapid response and low-cost measurement systems (Cao et al. 2017). 
The performance of the developed electrochemical dual-aptasensor array for osteopontin 
detection is affected by several experimental conditions such as incubation temperature, 
the concentration of aptamers, immobilization time of aptamers and contact time between 
aptamers and proteins. Consequently, as several factors are involved, finding the optimal 
experimental conditions that allow enhancing the performance of a dual-aptasensor array 
can be very laborious if no alternative approaches, such as experimental design and 
optimization tools, are used. In the aim of minimizing time-effort and optimizing all the 
affecting parameters simultaneously, a 2k factorial design was conducted with four factors 
(X1) aptamer concentration, (X2) time of aptamer immobilization into dual-screen printed 
gold electrodes (Dual-SPGE), (X3) the aptamer-protein interaction time and (X4) 
incubation temperature. An experimental design summary which includes design, factors 
and their levels, and response information are given in table 4.1. 
Table 4.1 Experimental design and results obtained using the 24 factorial design used for 
the optimization of the experimental conditions of the dual-aptasensor array 
Run 
Coded factors ∆𝐼 (%)
a 
RNA aptamer 
∆𝐼 (%) 
DNA aptamer 
X1 X2 X3 X4 SWV
b 
CVc 
(ox)d 
 
CV 
(red)e 
SWV CV 
(ox) 
CV 
(red) 
1 + - - + 10.83 7.80 11.18 12.29 16.00 13.35 
2 - - - - 40.93 21.58 28.74 53.86 32.26 36.91 
3 - - + + 38.26 9.21 9.60 44.55 9.60 12.78 
4 - - - + 36.78 10.42 11.13 26.68 28.74 8.10 
5 + + + - 37.28 13.38 14.13 48.53 19.44 19.37 
6 0 0 0 0 28.02 10.84 7.94 37.02 12.40 11.28 
7 - + + - 34.76 14.57 16.95 35.47 11.18 15.94 
8 - + - - 48.98 20.39 22.62 45.88 19.43 19.67 
9 - + + + 25.91 13.10 20.16 40.79 22.62 21.33 
10 0 0 0 0 32.41 10.78 10.66 32.78 18.69 9.33 
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Table 4.1 (continued) 
11 + - + + 0.00 0.00 2.35 29.09 7.94 11.72 
12 - - + - 39.09 16.94 21.06 35.70 14.13 17.74 
13 - + - + 46.65 15.45 19.43 50.64 11.13 17.44 
14 + - - - 39.13 10.99 18.69 48.40 2.35 20.82 
15 + + - + 45.64 17.03 19.44 43.76 14.06 19.32 
16 + + - - 26.51 7.58 12.40 35.96 20.16 15.53 
17 + + + + 38.58 11.78 14.06 47.74 21.06 17.73 
18 + - + - 37.67 15.60 16.00 33.26 15.16 16.81 
19 0 0 0 0 35.01 15.18 15.16 32.00 16.95 13.01 
a relative current change of the aptasensor; b square wave voltammetry; c cyclic voltammetry; 
doxidation; e reduction 
 
4.1. Effect of the experimental conditions on the response of the 
developed dual-aptasensor array  
For both SWV and CV techniques, the response of the dual-aptasensor array was 
determined by measuring the current change before and after osteopontin incubation 
according to the equation 3.1. Under the experimental conditions of the run 2 (4°C, 0.5 
µM of aptamer concentration, 20 min of aptamer incubation and 30 min of aptamer-
osteopontin interaction) (Table 4.1), the  peak current of SWV before osteopontin 
incubation for both DNA and RNA aptamer is equal to 52.2 µA and 40.9 µA respectively 
while it decreases to 24.0 µA and 24.1 µA respectively after protein incubation which 
correspond to a current decrease of 54% and 41%, respectively (Fig. 4.1 (a) and (b)). 
Under the same experimental conditions, the peak of CV also decreases after osteopontin 
incubation for both DNA and RNA aptamer from 43.7 µA and 41.7 µA to 26.9 µA and 
32.7 µA, respectively, which correspond to a current decrease of 32% and 22% 
respectively. The drop in the intensity of the current can be explained by an inhibition of 
the electron transfer after the osteopontin incubation. In fact, in the absence of 
osteopontin, the aptamer, which is immobilized into the gold surface of the WE, showed 
a dynamic state and flexible structure and allowed an efficient electron transfer between 
the electrode surface and the ferro/ferricyanide ([Fe(CN)6]
3-/4-) redox probe in which the 
complexed Fe(III) is reduced to Fe(II): Fe(CN)6
−3 +  𝑒− =  Fe(CN)6
−4. 
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After osteopontin binding, the aptamer conformation changes and forms a stable and rigid 
structure. This new conformation, blocks the electron transfer, resulting in a current 
decrease. 
A change in the the experimental conditions, alters the current decrease. Indeed, under 
the experimental conditions of the first run (44°C, 1.5 µM of aptamer concentration, 20 
min of aptamer incubation and 30 min of aptamer-osteopontin interaction) (Table 4.1), 
the peak of  SWV and CV decreases slightly  after the protein incubation which 
correspond to only 11% and 8%  respectively for DNA aptamer and, 12% and  8% 
respectively for RNA aptamer. 
 
 
Figure 4.1: Square wave voltammetry response of (a) DNA aptamer and (b) RNA aptamer and 
cyclic voltammetry response for (c) DNA aptamer and (d) RNA aptamer. 
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4.2. Effect of the type of aptamer and electrochemical technique on the 
dual-aptasensor response 
Besides estimating pure error and curvature, the center points allow analyzing the 
effect of the type of aptamer (RNA and DNA) and electrochemical technique (SWV and 
CV) on the dual-aptasensor array response because they are run in triplicate (run 6, 10 
and 19 in Table 4.1). The relative current changes (∆𝐼 %) relative to the center points are 
presented in Table 4.2. 
The significance of the difference between the obtained responses is evaluated by the 
two-way analysis of variance (ANOVA). Table 4.3 shows a statistically significant 
difference in the response of the dual-aptasensor array based on the type of the 
electrochemical technique (p-value < 0.0001). This significant difference is only between 
SWV and CVox or SWV and CVred. Both CVox and CVred give similar responses. Because 
CVox and CVred give similar responses, only the CVox will be considered for further 
analysis .These results confirm that SWV is more sensitive than CV. Indeed, it was 
reported that SWV allows detection limits as low as 10–8 M (Mendoza et al. 2015). The 
CV is more appropriate for the evaluation of the electrode surface such as its stability and 
purity and the cleaning of the electrode surface (Meirinho et al. 2015; Sethi 1994).  
The responses of the dual-aptasensor array in term of type of aptamer were similar. 
Indeed, the results showed (Table 4.3) that there was no statistical significant differences 
between the electrochemical current changes recorded with the RNA and DNA aptamers 
(p-value = 0.529). This result reveals that DNA and RNA aptamers used had similar 
sensitivities and binding affinities towards osteopontin. These similar behaviors were 
expected since it has been reported that both complex DNA aptamer-osteopontin and 
RNA aptamer-osteopontin had similar dissociation constants (Kd of 2.5 nM and 1.6 nM 
respectively (Meirinho 2015; Mi et al. 2009)) after an incubation of 30 minutes . The two 
kinds of aptamer have in their sequences, at different sites, a stem-loop which is involved 
in the binding to the osteopontin protein. These stem-loop structures are important as 
binding regions of the DNA or RNA aptamers to their targets  (Stoltenburg et al. 2007). 
Finally, the interaction between type of aptamer and type of the electrochemical technique 
used had a p-value equal to 0.776 (Table 4.3) which indicates that this interaction has no 
statistical-significant effect on the electrochemical response of the aptasensors. 
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Table 4.2: Results (relative current changes ∆𝐼 %) relative to the center points of the 
experimental design 
  Type of electrochemical technique 
  SWVa CVb (ox)c CV (red)d 
Type 
of aptamer 
DNA 
32 13.6 13 
32.8 10.9 9.3 
37 13.7 11.3 
RNA 
35 15.2 15.2 
32.4 10.8 10.7 
28 10.8 7.9 
a square wave voltammetry; b cyclic voltammetry; c oxidation; d reduction 
 
 
Table 4.3: Two way analysis of variance (ANOVA) of the results presented in Table 
4.2 
 Sum of Squares df Mean Square F Sig. 
Type of aptamer 3.20 1 3.20 0.42 0.52 
Type of electrochemical 
technique 
1768.81 2 884.40 116.10 < 0.0001 
Type of aptamer * type of 
electrochemical 
technique 
3.95 2 1.97 0.25 0.77 
Error 91.40 12 7.61 ---- ---- 
Total 8274.50 18 ---- ---- ---- 
Pairwise comparison 
Type of electrochemical 
technique 
Mean Difference Std. Error p-value 
CVa (ox)b 
CV (red) -0.94 2.22 1.000 
SWV -24.33 2.22 < 0.0001 
CV (red)c 
CV (ox) 0.94 2.22 1.000 
SWV -23.39 2.22 < 0.0001 
SWVd 
CV (ox) 24.33 2.22 < 0.0001 
CV (red) 23.39 2.22 < 0.0001 
a cyclic voltammetry; b oxidation; d square wave voltammetry; c reduction 
 
4.3. Optimization of the experimental conditions 
The main and interaction effects were calculated and are given in Table 4.4. 
Besides, the half-normal probability plots were also obtained using the software Design-
Expert®. From the Table 4.4 it can be noticed that X1 (aptamer concentration), X3 (the 
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aptamer-protein interaction time) and X4 (incubation temperature) have negative effects 
on the electrochemical current change response of the dual-aptasensor array regardless of 
the type of aptamer and electrochemical technique. This suggests that increasing X1 and 
X4 from the low level (0.5 µM, 30 min and 4°C, respectively) to the high level (1.5 µM, 
90 min and 44°C, respectively) will decrease the response of the aptasensor. On the other 
hand, the effect of X2 (immobilization time of the aptamer) is positive. This result means 
that the performance of the aptasensor increases when the factor passed from the low 
level (20 min) to the high level (60 min). However, the real meaning of the main effects 
may be limited if they are involved in significant interactions, which may turn out into 
misleading information, being therefore necessary to examine the statistical significant 
interactions.  
 
Table 4.4: Calculated effect of the main and interaction effects 
  ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 1 ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 2 ∆𝐼𝐶𝑉
𝐷𝑁𝐴 3 ∆𝐼𝐶𝑉
𝑅𝑁𝐴 4 
M
ai
n
 e
ff
ec
ts
 X1 -4.32 -9.46 -3.02 -4.69 
X2 8.12 7.70 1.26 2.59 
X3 -0.29 -5.49 -1.02 -2.09 
X4 -5.19 -7.71 -5.44 -4.53 
In
te
ra
ct
io
n
 e
ff
ec
ts
 
X1 X2 5.12 7.39 3.05 1.25 
X1 X3 4.85 3.34 2.56 1.42 
X1 X4 -3.12 -3.67 1.88 1.79 
X2 X3 -0.64 -2.33 2.62 0.18 
X2 X4 9.46 10.02 4.34 4.89 
X3 X4 7.49 -3.80 3.16 -2.07 
X1 X2 X3 4.36 6.33 0.48 0.76 
X1 X2 X4 2.36 11.57 -1.45 1.77 
X1 X3 X4 -1.66 -3.00 -4.38 -3.79 
X2 X3 X4 -9.50 -2.29 -3.16 0.18 
X1 X2 X3 X4 -0.63 0.17 0.82 0.16 
1 Relative current changes when using SWV as electrochemical technique and DNA as aptamer 
2 Relative current changes when using SWV as electrochemical technique and RNA as aptamer 
3 Relative current changes when using CV as electrochemical technique and DNA as aptamer 
4 Relative current changes when using CV as electrochemical technique and RNA as aptamer 
 
  
 
38 
 
In order to examine the magnitude of the factor effects, the pareto chart (Fig. 4.2) offers 
a simpler view of the relative effects. It is easy to notice from the pareto chart that the 
common most crucial effect  for the four response (∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴, ∆𝐼𝐶𝑉
𝐷𝑁𝐴 𝑎𝑛𝑑 ∆𝐼𝐶𝑉
𝑅𝑁𝐴 ) 
is the interaction effect  X2 X4 , whereas, the common least important effect is the 
interaction effect  X1 X2 X3 X4. Effects that are likely to be important are selected from 
the half-normal probability plot generated by the software Design-Expert in order to 
create a significant model. Effects with no significance may be included to keep a 
hierarchical model. To confirm the validity of the model, analysis of variance (ANOVA) 
and diagnostic residuals were used (Table 4.5).  
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Figure 4.2: Pareto chart of effects for the responses (a) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, (b) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , (c) ∆𝐼𝐶𝑉
𝑅𝑁𝐴 and 
(d) ∆𝐼𝐶𝑉
𝐷𝑁𝐴 
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Table 4.5: Analysis of variance (ANOVA) for the four created model and their diagnostic 
residuals 
  SS DF MS F-value p-value 
Model ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 1 1738.60 14.00 124.19 23.05 0.012 
 ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 2 2505.47 14.00 178.96 21.42 0.013 
 ∆𝐼𝐶𝑉
𝐷𝑁𝐴 3 511.30 13.00 39.33 18.27 0.006 
 ∆𝐼𝐶𝑉
𝑅𝑁𝐴 4 426.83 13.00 32.83 10.11 0.019 
Curvature ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 79.32 1.00 79.32 14.72 0.031 
 ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 14.26 1.00 14.26 1.71 0.28 
 ∆𝐼𝐶𝑉
𝐷𝑁𝐴 9.58 1.00 9.58 4.45 0.10 
 ∆𝐼𝐶𝑉
𝑅𝑁𝐴 0.90 1.00 0.90 0.28 0.62 
Residuals ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 16.17 3.00 5.39 ---- ---- 
 ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 25.06 3.00 8.35 ---- ---- 
 ∆𝐼𝐶𝑉
𝐷𝑁𝐴 8.61 4.00 2.15 ---- ---- 
 ∆𝐼𝐶𝑉
𝑅𝑁𝐴 12.99 4.00 3.25 ---- ---- 
Lack of fit ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 1.59 1.00 1.59 0.22 0.68 
 ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 0.12 1.00 0.12 0.01 0.93 
 ∆𝐼𝐶𝑉
𝐷𝑁𝐴 3.58 2.00 1.79 0.71 0.58 
 ∆𝐼𝐶𝑉
𝑅𝑁𝐴 0.23 2.00 0.12 0.02 0.98 
Pure error ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 14.57 2.00 7.29 ---- ---- 
 ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 24.94 2.00 12.47 ---- ---- 
 ∆𝐼𝐶𝑉
𝐷𝑁𝐴 5.04 2.00 2.52 ---- ---- 
 ∆𝐼𝐶𝑉
𝑅𝑁𝐴 12.75 2.00 6.38 ---- ---- 
Models 𝑅 2 𝑅𝑎𝑑𝑗𝑢𝑠𝑡𝑒𝑑
2  Q2 Adequate precision 
∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 0.99 0.94 0.74 19.51 
∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 0.99 0.94 0.96 18.46 
∆𝐼𝐶𝑉
𝐷𝑁𝐴 0.98 0.92 0.53 18.97 
∆𝐼𝐶𝑉
𝑅𝑁𝐴 0.97 0.87 0.90 13.37 
1 Relative current changes when using SWV as electrochemical technique and DNA as aptamer 
2 Relative current changes when using SWV as electrochemical technique and RNA as aptamer 
3 Relative current changes when using CV as electrochemical technique and DNA as aptamer 
4 Relative current changes when using CV as electrochemical technique and RNA as aptamer 
 
The four created models relative to the four responses (∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴, ∆𝐼𝐶𝑉
𝐷𝑁𝐴 𝑎𝑛𝑑 ∆𝐼𝐶𝑉
𝑅𝑁𝐴) 
were found to be statistically significant (p-value= 0.0125; 0.0139; 0.0063 and 0.0191 
respectively) and did not show lack-of-fit (p-value=0.6863; 0.9304; 0.5847 and 0.9822 
respectively). In addition, they showed an acceptable determination coefficients (R2 = 
0.9907; 0.9900; 0.9834; 0.9704) that explain 99.07%, 99%, 98.34% and 97.04% of the 
response variability respectively, as well as a satisfactory adjusted determination 
coefficient (R2adjusted = 0.9477; 0.9438; 0.9296 and 0.8745 respectively). Also, a 
satisfactory prediction determination coefficients were obtained (Q2 = 0.7491; 0.9655; 
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0.5380 and 0.9010, respectively) showing that the prediction performance of the proposed 
models is acceptable. It is true that the prediction determination coefficients of the model 
relative to the response ∆𝐼𝐶𝑉
𝐷𝑁𝐴 is  less than 0.6 but it can be considered as satisfactory Q2 
because the difference is very small. Moreover, the model showed an adequate precision 
(equal to 19.5155; 18.4672; 18.9792 and 13.3782, respectively), which means that the 
proposed models can be used to navigate the design space and for optimization purposes. 
The curvature of the model relative to the responses ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 is significant (p-value 0.0312) 
which means that the values of the used center points are either higher or lower than those 
predicted by the factorial design. This indicates that the design is in the region of an 
optimum. The curvatures of the models relative to the responses ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴, ∆𝐼𝐶𝑉
𝐷𝑁𝐴  and 
∆𝐼𝐶𝑉
𝑅𝑁𝐴  are not significant (p-value = 0.2825, 0.1026, 0.6269, respectively) which means 
that the response of the dual-aptasensor array can be predicted by a first-order model 
equation: 
 
∆𝐼(%) = 𝛽0 +  ∑ 𝛽𝑖𝑋𝑖
4
𝑖=1  +  ∑ 𝛽𝑖𝑗𝑋𝑖𝑋𝑗
6
𝑖<𝑗 + ∑ 𝛽𝑖𝑗𝑘𝑋𝑖𝑋𝑗
3
𝑖<𝑗<𝑘 𝑋𝑘 + 𝛽1234𝑋1𝑋2𝑋3. 
 
The parameters (β’s coefficient) of the regression model equations are shown in Table 
4.6 and Table 4.7. The statistic analyses of the four created models do not reveal any 
problems so we can look at the significant factor effects in order to optimize the 
experimental condition of the dual-aptasensor array. 
 
Table 4.6: Regression parameters (for the coded factors) of the two models for the 
responses ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴  and ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 
 
 
Coded 
factors 
Model parameters 
(eq 2.3) 
∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 (%) 1 ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴(%) 2 
𝛽’s coefficient p-value 𝛽’s coefficient p-value 
Intercept β0 39.54  34.19  
X1 β1 -2.16 0.03 -4.73 0.007 
X2 β2 4.06 0.006 3.85 0.032 
X3 β3 -0.15 0.81 -2.74 0.01 
X4 β4 -2.60 0.02 -3.86 0.01 
X1 X2 β12 2.56 0.02 3.70 0.1 
X1 X3 β13 2.42 0.02 1.67 0.01 
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1 Relative current changes when using SWV as electrochemical technique and DNA as aptamer 
2 Relative current changes when using SWV as electrochemical technique and RNA as aptamer 
 
Table 4.7: Regression parameters (for the coded factors) of the two models for the 
responses ∆𝐼𝐶𝑉
𝐷𝑁𝐴  and  ∆𝐼𝐶𝑉
𝐷𝑁𝐴  
1 Relative current change when using CV as electrochemical technique and DNA as aptamer 
2 Relative current change when using CV as electrochemical technique and RNA as aptamer 
Table 4.6 (continued) 
X1 X4 β14 -1.56 0.07 -1.84 0.08 
X2 X3 β23 -0.32 0.62 -1.16 0.20 
X2 X4 β24 4.73 0.003 5.01 0.07 
X3 X4 β34 3.75 0.007 -1.90 0.006 
X1 X2 X3 β123 2.18 0.03 3.16 0.02 
X1 X2 X4 β124 1.18 0.13 5.79 0.12 
X1 X3 X4 β134 -0.83 0.24 -1.50 0.004 
X2 X3 X4 β234 -4.75 0.003 -1.14 0.21 
X1 X2 X3 X4 β1234 ---- ---- ---- ---- 
Coded 
factors 
Model parameters 
(eq 2.3) 
∆𝐼𝐶𝑉
𝐷𝑁𝐴 (%)1 ∆𝐼𝐶𝑉
𝑅𝑁𝐴(%)2 
𝛽’s coefficient p-value 𝛽’s coefficient p-value 
Intercept β0 14.68 ---- 12.86 ---- 
X1 β1 -1.51 0.01 -2.35 0.006 
X2 β2 0.63 0.16 1.3 0.04 
X3 β3 -0.51 0.23 -1.04 0.08 
X4 β4 2.72 0.001 -2.27 0.007 
X1 X2 β12 1.52 0.01 0.63 0.23 
X1 X3 β13 1.28 0.02 0.71 0.18 
X1 X4 β14  0.94 0.06 0.9 0.11 
X2 X3 β23 1.31 0.02 0.088 0.85 
X2 X4 β24 2.17 0.004 2.44 0.005 
X3 X4 β34 1.58 0.01 -1.03 0.08 
X1 X2 X3 β123   0.38 0.44 
X1 X2 X4 β124 -0.72 0.11 0.88 0.12 
X1 X3 X4 β134 -2.19 0.003 -1.9 0.01 
X2 X3 X4 β234 -1.58 0.01 ---- ---- 
X1 X2 X3 X4 β1234 ---- ---- ---- ---- 
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The X1 X2, X1 X4, and X2 X4 interactions are the key to solving the problem of 
optimization. The X1X2 interaction for the four models (∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴, ∆𝐼𝐶𝑉
𝐷𝑁𝐴  and 
∆𝐼𝐶𝑉
𝑅𝑁𝐴 are plotted in the Fig. 4.3  which show how the aptamer concentration and time of 
immobilization of the aptamer interact to affect the response of the aptasensor. Two lines 
appear on the plots, bracketed by least significant difference (LSD) bars at either end. The 
lines are far from parallel, indicating quite different effects of changing the concentration 
of aptamer (X1). In Fig. 4.3 ((a) and (b)) the line is almost flat when the immobilization 
time is high (X2 = 60 min), which indicates that the system is unaffected by aptamer 
concentration. In Fig. 4.3 ((c) and (d)), when the immobilization time is set at its high 
level, the change in aptasensor response is also small. However, when the time is at the 
low level, the line angles decreases indicating a strong negative effect due to the increased 
aptamer concentration. The combination of high concentration and low time is bad for 
the response. When the aptamer concentration is set at its low level (X1 = 0.5 µM), the 
response remains high regardless of the time setting. In fact, the LSD bars overlap at this 
end of the interaction graph, which implies that there is no significant difference in the 
aptasensor response. From this interaction (X1 X2), we conclude that the best response 
would appear to be obtained when: X1 and X2 are both at the high level or when X1 at the 
low level regardless of X2 level. The second solution is definitely better than the first one, 
especially when the immobilization time is set at the low level because it allows a 
reduction in the operational costs and time. However, we have to check if the 
immobilization time at its high level induces or not a better response when interacting 
with other factors.  
Fig. 4.4 exhibit the same pattern of again the nonparallel lines that are characteristic of a 
powerful two-factor interaction. The effect of immobilization time on the aptasensor 
response depends on the level of temperature, represented by the two lines on the graph. 
On the top line, the least significant difference (LSD) bars overlap from left to right which 
indicates that at low temperature (X4 = 4°C), there is not much, if any, effect. However, 
the aptasensor response differs for the lower line on the graphs where incubation 
temperature is set at its high level (X4 = 44°C). Here the LSD bars do not overlap, 
indicating that the effect of immobilization time is significant. In fact, when the time is at 
its low level, the temperature has the largest effect on aptasensor response among all the 
other factors whereas; it has not a significant effect when the time is at its high level. In 
fact, incubation temperature has little effect at high time but the largest effect on the 
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aptasensor response at low immobilization time. Therefore, the best aptasensor response 
for this interaction is reached when X2 and X4 are set at the low level or when the time is 
at its high level regardless of the temperature level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Interaction graphs of factors X1 (aptamer concentration) versus X2 (aptamer 
immobilization time) for the responses (a) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, (b) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , (c) ∆𝐼𝐶𝑉
𝐷𝑁𝐴 and (d) ∆𝐼𝐶𝑉
𝑅𝑁𝐴   
(a) (b) 
(c) (d) 
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Figure 4.4: Interaction graphs of factors X2 (aptamer immobilization time) versus X4 (incubation 
temperature) for the responses (a) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, (b) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , (c) ∆𝐼𝐶𝑉
𝐷𝑁𝐴 and (d) ∆𝐼𝐶𝑉
𝑅𝑁𝐴   
 
From the interaction X1X4 (Fig. 4.5 (c) and (d)), we note that the spread of the points on 
the right side of the graph (where aptamer concentration is high) is smaller than the spread 
between the points at the left side of the graph (where aptamer concentration is low.) In 
other words, the effect of temperature is less significant at the high level of X1. Therefore, 
the combination of low temperature and low aptamer concentration gives the best 
response. Whereas the best results in Fig. 4.5 ((a) and (b)) are obtained when the 
concentration is also at its low level regardless of the temperature. 
For the interaction X3X4 (Fig. 4.6), DNA and RNA aptamers do not exhibit the same 
pattern of interaction. In fact, for the DNA aptamer (Fig. 4.6 (a) and (c)) the best response 
is achieved when X3 and X4 are both at their low levels. When the temperature is set at 
(a) (b) 
(c) (d) 
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the high level, an increase in the interaction time between aptamer and osteopontin 
improve slightly the response. However, for the RNA aptamer (Fig. 4.6 (b) and (d)), an 
increase in the interaction time between aptamer and osteopontin when the temperature 
is set at the high level, deteriorate the response. In this case, the best result is obtained 
when the temperature is at its low level regardless of the interaction time or when the 
interaction time is low and the temperature is high. 
  
 
 
 
Figure 4.5: Interaction graphs of factors X1 (aptamer concentration) versus X4 (incubation 
temperature) for the responses (a) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, (b) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , (c) ∆𝐼𝐶𝑉
𝐷𝑁𝐴 and (d) ∆𝐼𝐶𝑉
𝑅𝑁𝐴   
 
 
  
(b) (a) 
(c) (d) 
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Figure 4.6: Interaction graphs of factors X3 (interaction time between aptamer and osteopontin) 
versus X4 (incubation temperature) for the responses (a) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, (b) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , (c) ∆𝐼𝐶𝑉
𝐷𝑁𝐴 and (d) 
∆𝐼𝐶𝑉
𝑅𝑁𝐴   
 
Taking into account all the analyzed interactions, we conclude that the combination of 
low aptamer concentration, low time of aptamer immobilization, low interaction time 
between aptamer and osteopontin and low incubation temperature enhances the 
performance of the aptasensor with the main advantage of reducing operational costs and 
time. Under these conditions, an electrochemical current changes of 54%, 41%, 32% and 
22% in ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 and ∆𝐼𝐶𝑉
𝐷𝑁𝐴 respectively were obtained which corresponds to an 
improvement of about 56%, 24%, 50% and 23% respectively comparing to the values of 
single aptasensor (aptamer concentration: 0.4µM; incubation temperature: 24°C; 
interaction time between aptamer and protein: 60 min; aptamer immobilization time: 40 
min), previously reported in the literature  (Meirinho et al. 2015; Meirinho 2016). 
(a) (b) 
(c) (d) 
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However, it is worth noting that the surface of the WE used in the single aptasensor is 
smaller than the WE used for the developed dual-aptasensor. In addition, an improvement 
of about 61% and 12% in ∆𝐼𝐶𝑉
𝐷𝑁𝐴 and ∆𝐼𝐶𝑉
𝑅𝑁𝐴  respectively was achieved comparing to the 
reported values of a dual-aptasensor operating under non-optimized  experimental 
conditions (aptamer concentration: 0.4µM; incubation temperature: 24°C; interaction 
time between aptamer and protein: 60 min; aptamer immobilization time: 40 min) 
(Meirinho 2016). 
The 3 D surface graphs (Fig. 4.7) show the common best experimental conditions for the 
4 four responses ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴, ∆𝐼𝐶𝑉
𝐷𝑁𝐴 𝑎𝑛𝑑 ∆𝐼𝐶𝑉
𝑅𝑁𝐴  that allow enhancing the performance 
of the developed electrochemical dual-aptasensor array.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: 3 D surface graphs of the optimal experimental conditions for the responses ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, 
(b) ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 , (c) ∆𝐼𝐶𝑉
𝐷𝑁𝐴 and (d) ∆𝐼𝐶𝑉
𝑅𝑁𝐴  at 20 min of aptamer incubation and 30 min of aptamer-
osteopontin interaction. 
(a) (b) 
(c) (d) 
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 In this work, an electrochemical dual-aptasensor array was built for the possible 
early detection of cancer. The effects of four operating experimental conditions  (aptamer 
concentration, time of aptamer immobilization into dual-screen printed gold electrodes 
(Dual-SPGE), the aptamer-protein interaction time and  incubation temperature) and of 
their interactions on the signal response of the developed dual-aptasensor were 
experimentally investigated using two electrochemical techniques, namely the SWV and 
CV. 
The modeling and optimization of the signal response of the developed dual-aptasensor 
array was satisfactorily performed using a 2k factorial design methodology that allowed 
establishing the optimal experimental conditions that enabled enhancing the 
electrochemical current change of the signal response.  
The results obtained showed that the established models can be used to predict the signal 
response of the aptasensor under any given conditions within the experimental range 
studied (aptamer concentration from 0.5 µM to 1.5 µM, incubation temperature from 4°C 
to 44°C, time of aptamer immobilization between 20 min and 60 min and time of aptamer-
osteopontin interaction between 30 min and 90 min). Temperature and aptamer 
concentration were found to be the most significant parameters. In addition, under the 
optimized experimental conditions an effective enhancement of the signal response was 
achieved. A 53.86%  and 41%  in ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴 and ∆𝐼𝑆𝑊𝑉
𝑅𝑁𝐴 respectively were obtained in 
experiment conducted under the optimized experimental conditions (aptamer 
concentration of 0.5 µM for both DNA and RNA aptamers;  an incubation temperature 
of 4ºC; 20 min aptamer immobilization time into the Dual-SPGE at 4ºC; and aptamer-
protein interaction time of 30 min). 
Since the preliminary experimental design performed pointed out that the optimized 
experimental conditions were at their low level, a new factorial design with a reduced 
number of factors should be tested in order to verify if the signal response could be further 
improved. From the results already obtained, the new design will be a reduced one with 
only three factors since it would not be feasible to carried out assays at temperatures lower 
than 4°C, otherwise the working solutions may freeze. For ∆𝐼𝑆𝑊𝑉
𝐷𝑁𝐴, a significant curvature 
was detected. Therefore, the 2k factorial design should be augmented into a response 
surface methodology based on a rotable central composite design by locating new points 
along the axes of the factor space. 
Chapter 5                                                                                          Conclusion and future perspectives 
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Finally, this study can be seen as a useful input and an effective contribution for the 
development of more performant aptasensor since statistical design of experiments have 
been only applied in a few studies. 
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